Edward E. Walsh mostly deals with Immunology, Virology, Antibody, Virus and Viral disease. His research integrates issues of Young adult, Internal medicine and Respiratory system in his study of Immunology. As a part of the same scientific family, Edward E. Walsh mostly works in the field of Internal medicine, focusing on Influenza A virus and, on occasion, Cohort study, Intensive care medicine, Intensive care, Cohort and Epidemiology.
The Virology study combines topics in areas such as Coronavirus, Monoclonal antibody and Immunoglobulin A. His research investigates the connection with Antibody and areas like Antigen which intersect with concerns in Flavivirus, B cell and Immunoglobulin heavy chain. Edward E. Walsh interconnects Respiratory Syncytial Virus Vaccines, Fusion protein, Glycoprotein and Microbiology in the investigation of issues within Virus.
His primary areas of investigation include Virology, Immunology, Virus, Respiratory system and Antibody. In his research on the topic of Virology, Molecular biology is strongly related with Monoclonal antibody. His Immunology research is multidisciplinary, incorporating elements of Respiratory disease and Internal medicine.
Edward E. Walsh focuses mostly in the field of Internal medicine, narrowing it down to matters related to Serology and, in some cases, Cardiopulmonary disease. His studies in Virus integrate themes in fields like Humoral immunity and Immune system. His Antibody research is multidisciplinary, incorporating perspectives in Flavivirus and Immunity.
Edward E. Walsh mainly focuses on Virus, Immunology, Respiratory system, Coronavirus disease 2019 and Internal medicine. His Virus study is focused on Virology in general. His Airway research extends to Immunology, which is thematically connected.
His study in Respiratory system is interdisciplinary in nature, drawing from both CX3CR1, Delayed diagnosis and Intensive care unit. His Internal medicine research incorporates themes from Transmission and Outbreak. He has researched Antibody in several fields, including Safety tolerability, Protein subunit and Vaccination.
The scientist’s investigation covers issues in Immunology, Virus, Antibody, Internal medicine and Immunogenicity. Edward E. Walsh has included themes like CX3CR1, Lung, Respiratory system and In situ hybridization in his Virus study. His Severe acute respiratory syndrome coronavirus 2 and Index case study, which is part of a larger body of work in Internal medicine, is frequently linked to Ultraviolet light and Candida auris, bridging the gap between disciplines.
The study incorporates disciplines such as Tolerability and Pandemic, Coronavirus disease 2019 in addition to Immunogenicity. The various areas that Edward E. Walsh examines in his Reactogenicity study include Young adult and Vaccination. Edward E. Walsh studied RNA and Coronavirus that intersect with Virology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus.
Evelyn A. Kurt-Jones;Lana Popova;Laura Kwinn;Lia M. Haynes.
Nature Immunology (2000)
Respiratory syncytial virus infection in elderly and high-risk adults.
Ann R. Falsey;Patricia A. Hennessey;Maria A. Formica;Christopher Cox.
The New England Journal of Medicine (2005)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
Edward E. Walsh;Robert W. Frenck;Ann R. Falsey;Ann R. Falsey;Nicholas Kitchin.
The New England Journal of Medicine (2020)
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.
Mark J. Mulligan;Kirsten E. Lyke;Nicholas Kitchin;Judith Absalon.
Nature (2020)
Immunity to and Frequency of Reinfection with Respiratory Syncytial Virus
Caroline Breese Hall;Edward E. Walsh;Christine E. Long;Kenneth C. Schnabel.
The Journal of Infectious Diseases (1991)
Respiratory Syncytial Virus Infection in Adults
Ann R. Falsey;Edward E. Walsh.
Clinical Microbiology Reviews (2000)
Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study.
Hall Cb;McBride Jt;Walsh Ee;Bell Dm.
The New England Journal of Medicine (1983)
Human Metapneumovirus Infections in Young and Elderly Adults
Ann R Falsey;Dean Erdman;Larry J Anderson;Edward E Walsh.
The Journal of Infectious Diseases (2003)
Occurrence of Groups A and B of Respiratory Syncytial Virus over 15 Years: Associated Epidemiologic and Clinical Characteristics in Hospitalized and Ambulatory Children
Caroline Breese Hall;Edward E. Walsh;Kenneth C. Schnabel;Christine E. Long.
The Journal of Infectious Diseases (1990)
Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus.
G A Prince;A B Jenson;V G Hemming;B R Murphy.
Journal of Virology (1986)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Rochester Regional Health
University of Rochester Medical Center
University of Rochester Medical Center
University of Rochester
Seattle Children's Hospital
University of Maryland, Baltimore
University of New South Wales
National Institute of Allergy and Infectious Diseases
Pfizer (United States)
Pfizer (United States)
Technical University of Berlin
Florida Institute for Human and Machine Cognition
Lawrence Berkeley National Laboratory
Kyoto University
University of La Rochelle
New South Wales Department of Primary Industries
University of California, Davis
Nanjing Normal University
University of Western Australia
Aarhus University
Duke University
University of Veterinary Medicine Vienna
University of Kent
University Hospital of Bern
Norwegian School of Sport Sciences
Stanford University